Page 13 - 南京医科大学学报自然科学版
P. 13
第43卷第12期 李杨夏,佟 晴,程 越,等. TLR2/NF⁃κB通路介导MPP 诱导的RSC96细胞凋亡与自噬[J].
+
2023年12月 南京医科大学学报(自然科学版),2023,43(12):1623-1629 ·1629 ·
ing,2021,100:91-105 tion in Parkinson’s disease:results from the faroese Par⁃
[6] LIU J,LIU W,YANG H. Balancing apoptosis and autoph⁃ kinson’s disease cohort[J]. Neurosci Lett,2022,785:
agy for Parkinson’s disease therapy:targeting BCL⁃2[J]. 136789
ACS Chem Neurosci,2019,10(2):792-802 [19] TAVEGGIA C,FELTRI M L. Beyond wrapping:canonical
[7] WIJEYEKOON R S,KRONENBERG ⁃ VERSTEEG D, and noncanonical functions of schwann cells[J]. Annu
SCOTT K M,et al. Peripheral innate immune and bacteri⁃ Rev Neurosci,2022,45:561-580
al signals relate to clinical heterogeneity in Parkinson’s [20] DONADIO V,INCENSI A,RIZZO G,et al. Phosphorylat⁃
disease[J]. Brain Behav Immun,2020,87:473-488 ed α⁃synuclein in skin Schwann cells:a new biomarker
[8] SUN L,JIANG W W,WANG Y,et al. Phosphorylated α⁃ for multiple system atrophy[J]. Brain,2023,146(3):
synuclein aggregated in Schwann cells exacerbates pe⁃ 1065-1074
ripheral neuroinflammation and nerve dysfunction in Par⁃ [21]TU H Y,YUAN B S,HOU X O,et al. α⁃synuclein sup⁃
kinson’s disease through TLR2/NF⁃κB pathway[J]. Cell presses microglial autophagy and promotes neurodegener⁃
Death Discov,2021,7(1):289 ation in a mouse model of Parkinson’s disease[J]. Aging
[9] DZAMKO N,GYSBERS A,PERERA G,et al. Toll⁃like Cell,2021,20(12):e13522
receptor 2 is increased in neurons in Parkinson’s disease [22] HAN X,LIU Y,DAI Y,et al. Neuronal SH2B1 attenuates
brain and may contribute to alpha ⁃ synuclein pathology apoptosis in an MPTP mouse model of Parkinson’s dis⁃
[J]. Acta Neuropathol,2017,133(2):303-319 ease via promoting PLIN4 degradation[J]. Redox Biol,
[10] KWON S,IBA M,MASLIAH E,et al. Targeting microgli⁃ 2022,52:102308
al and neuronal toll⁃like receptor 2 in synucleinopathies [23] WANG X W,YUAN L J,YANG Y,et al. IGF⁃1 inhibits
[J]. Exp Neurobiol,2019,28(5):547-553 MPTP/MPP(+)⁃induced autophagy on dopaminergic neu⁃
[11] CHEDID J,LABRADOR⁃GARRIDO A,ZHONG S,et al. rons through the IGF⁃1R/PI3K⁃Akt⁃mTOR pathway and
A small molecule toll⁃like receptor antagonist rescues α⁃ GPER[J]. Am J Physiol Endocrinol Metab,2020,319
synuclein fibril pathology[J]. J Biol Chem,2022,298 (4):734-743
(8):102260 [24] CHALLIS C,HORI A,SAMPSON T R,et al. Gut⁃seeded
[12] RONG Z,SHEN F,WANG Y,et al. Phosphorylated α ⁃ α⁃synuclein fibrils promote gut dysfunction and brain pa⁃
synuclein and phosphorylated tau⁃protein in sural nerves thology specifically in aged mice[J]. Nat Neurosci,2020,
may contribute to differentiate Parkinson’s disease from 23(3):327-336
multiple system atrophy and progressive supranuclear pa⁃ [25] NEMUTLU S D,AKÇAY G,YILDIRIM S,et al. Vortiox⁃
ralysis[J]. Neurosci Lett,2021,756:135964 etine ameliorates motor and cognitive impairments in the
[13] CHENG Y,TONG Q,YUAN Y,et al. α⁃Synuclein induc⁃ rotenone⁃induced Parkinson’s disease via targeting TLR⁃
es prodromal symptoms of Parkinson’s disease via activat⁃ 2 mediated neuroinflammation[J]. Neuropharmacology,
ing TLR2/MyD88/NF⁃κB pathway in Schwann cells of va⁃ 2022,208:108977
gus nerve in a rat model[J]. J Neuroinflammation,2023, [26] SEIMON T A,NADOLSKI M J,LIAO X,et al. Atherogen⁃
20(1):36 ic lipids and lipoproteins trigger CD36⁃TLR2⁃dependent
[14] 汪 烨,姜雯雯,吴 晶,等. 1⁃甲基⁃4⁃苯基⁃1,2,3,6⁃ apoptosis in macrophages undergoing endoplasmic reticu⁃
四氢吡啶制备的帕金森病模型小鼠对帕金森病自主神 lum stress[J]. Cell Metab,2010,12(5):467-482
经功能障碍的适用性研究[J]. 临床神经病学杂志, [27] ADHIKARLA S V,JHA N K,GOSWAMI V K,et al. TLR⁃
2022,35(1):49-55 mediated signal transduction and neurodegenerative disor⁃
[15] 高健成,陆晨飞,张梓枫,等. 胶质瘤干细胞来源的外泌 ders[J]. Brain Sci,2021,11(11):1373
体促进胶质瘤恶性进展[J]. 南京医科大学学报(自然 [28] CHUNG L Y,LIN Y T,LIU C,et al. Neuroinflammation
科学版),2022,42(12):1658-1663 upregulated neuronal toll⁃like receptors 2 and 4 to drive
[16] 李 蓉,刘 露,朱夕陈,等. 洛伐他汀调节NMDA受体 synucleinopathy in neurodegeneration[J]. Front Pharma⁃
功能减缓 NMDA 兴奋性毒性损害[J]. 南京医科大学 col,2022,13:845930
学报(自然科学版),2023,43(4):468-474 [29] WASKO N J,KULAK M H,PAUL D,et al. Systemic
[17] QI S,YIN P,WANG L,et al. Prevalence of Parkinson’s TLR2 tolerance enhances central nervous system remye⁃
disease:a community⁃based study in China[J]. Mov Dis⁃ lination[J]. J Neuroinflammation,2019,16(1):158
ord,2021,36(12):2940-2944 [收稿日期] 2023-05-19
[18] BERG A,BECH S,AASLY J,et al. Autonomic dysfunc⁃ (本文编辑:唐 震)